Know Cancer

or
forgot password


N/A
18 Years
90 Years
Not Enrolling
Both
Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

Thank you

Trial Information


Inclusion Criteria:



- Patients with CRLM

- Surgery: resection and/or ablation

- preoperative chemotherapy and/or biological agents are allowed

- postoperative chemotherapy and/or biological agents are allowed

- simultaneous colorectal resection is allowed

Exclusion Criteria:

- primary liver cancer

- benign liver tumors

- pregnancy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

overall survival

Outcome Time Frame:

5 years

Safety Issue:

No

Authority:

Belgium: Ethics Committee

Study ID:

CRLM-MILS

NCT ID:

NCT01356706

Start Date:

October 2002

Completion Date:

July 2012

Related Keywords:

  • Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators
  • liver metastases
  • colorectal cancer
  • surgery
  • prognosis
  • Colorectal Neoplasms

Name

Location